10 Followers on Owler

Akers Bio

Read more
Howard R. Yeaton's photo - Interim-CEO of Akers Bio

Interim-CEO

Howard R. Yeaton

CEO Approval Rating

88/100

Founded:

1989

Status:

PrivateMerger Pending with MD Pharmaceuticals, Inc

Est. Annual Revenue
$ < 1M
Agree?
Est. Employees
4
Agree?

AKERS BIO TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Akers Bio's company profile
Howard R. Yeaton's photo - Interim-CEO of Akers Bio

Howard R. Yeaton

Interim-CEO

88/100
4
$21.8M
$ < 1M
View Profile
1
Akers Bio's Competitor - ACON logo
CEO Avatar

Jinn-Nan Lin

President

89/100
1,500
- -
$50M
View Profile
2
Akers Bio's Competitor - Immucor logo
Avi Pelossof's photo - President & CEO of Immucor

Avi Pelossof

President & CEO

59/100
1,050
- -
$380M
View Profile
3
Akers Bio's Competitor - OraSure logo
Stephen S. Tang's photo - Chairman & CEO of OraSure

Stephen S. Tang

Chairman & CEO

82/100
398
$21.3M
$227.1M
View Profile
4
Akers Bio's Competitor - Quidel Corporation logo
Douglas C. Bryant's photo - President & CEO of Quidel Corporation

Douglas C. Bryant

President & CEO

85/100
1,224
$71M
$1.8B
View Profile
5
Akers Bio's Competitor - SeraCare logo
Michael Sweatt's photo - General Manager of SeraCare

Michael Sweatt

General Manager

82/100
157
$82M
$26M
View Profile
6
Akers Bio's Competitor - ZeptoMetrix logo
Shawn R. Smith's photo - President & CEO of ZeptoMetrix

Shawn R. Smith

President & CEO

88/100
100
- -
$15M
View Profile
7
Akers Bio's Competitor - Randox logo
Peter Fitzgerald's photo - Managing Director of Randox

Peter Fitzgerald

Managing Director

36/100
918
- -
$119.7M
View Profile
8
Akers Bio's Competitor - Vircell logo
CEO Avatar

CEO

- -
31
- -
$7.2M
View Profile
9
Akers Bio's Competitor - Viro Immun Diagnostics logo
Bruno Rosen's photo - Managing Director of Viro Immun Diagnostics

Bruno Rosen

Managing Director

48/100
100
- -
$60M
View Profile
10
Akers Bio's Competitor - DIALAB logo
CEO Avatar

CEO

- -
200
- -
$25M
View Profile
11
Akers Bio's Competitor - CTHA logo
CEO Avatar

CEO

- -
49
$350K
$4.1M
View Profile
12
Akers Bio's Competitor - Epicentre Technologies Corporation logo
CEO Avatar

CEO

- -
60
- -
$4.4M
View Profile

Missing a competitor? Contribute!

ACON is Akers Bio's #1 rival. ACON was founded in 1996 in San Diego, California. ACON is in the Health Care Equipment field. ACON generates $49.1M more revenue than Akers Bio.

Immucor is one of Akers Bio's top competitors. Immucor is headquartered in Norcross, Georgia, and was founded in 1982. Immucor competes in the Health Care Equipment field. Immucor generates 43,886% the revenue of Akers Bio.

OraSure is seen as one of Akers Bio's top competitors. OraSure was founded in 1987, and its headquarters is in Bethlehem, Pennsylvania. OraSure operates in the Health Care Services industry. OraSure has 566 more employees than Akers Bio.

Akers Bio Acquisitions

No recent acquisitions found related to Akers Bio

Akers Bio Funding History

Since Akers Bio was founded in 1989, it has participated in 5 rounds of funding. In total Akers Bio has raised $21.8M. Akers Bio's last funding round was on Aug 2020 for a total of $6.8M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
Aug 2020
$6.8M
-
Private Placement
May 2020
$4.8M
-
Equity
Mar 2020
$1.2M
Private Placement
Jan 2018
$6.9M
-
Equity
Mar 2017
$2M
-

Since Akers Bio was founded in 1989, it has participated in 5 rounds of funding. In total Akers Bio has raised $21.8M. Akers Bio's last funding round was on Aug 2020 for a total of $6.8M

Akers Bio Investments

No recent investments found related to Akers Bio

Akers Bio News

March 22, 2021MarketScreener

Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals

(marketscreener.com) Akers Biosciences, Inc , today announced that it has scheduled its general meeti... See more »
February 23, 2021Benzinga

Akers Biosciences' Proposed Partner MyMD's Lead Candidate Inhibits Fibrotic Diseases-Associated Biomarkers

Akers Biosciences Inc (NASDAQ: AKER) and its proposed merger partner MyMD Pharmaceuticals Inc have an... See more »
February 23, 2021BioSpace

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

Akers Biosciences, Inc. (Nasdaq: AKER), with its proposed merger partner MyMD Pharmaceuticals, Inc. (... See more »
February 18, 2021MarketScreener

Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission

(marketscreener.com) Findings of study published in PLOS One found a highly significant correlation b... See more »
February 17, 2021MarketScreener

Responds to Erroneous Earnings Call Press Release

(marketscreener.com) Akers Biosciences, Inc. confirmed that a press release issued earlier today with... See more »

Akers Bio Press Releases

August 15, 2019GlobeNewswire

Akers Biosciences Reports Q2 2019 Earnings

Continued Progress Toward Positioning the Company for Strategic Alternatives... See more »
May 20, 2019GlobalNewswire

Akers Biosciences Reports Q1 2019 Earnings

Continued Progress Toward Positioning the Company for Strategic Alternatives... See more »
November 20, 2018Emerging Growth

AKER) The Great Cannabis Comeback Defines Big Board Valuations

Miami, FL - November 20, 2018 (EmergingGrowth.com NewsWire) - EmergingGrowth.com, a leading independe... See more »
August 9, 2018StreetInsider

The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 9, 2018 / The Schall Law Firm, a national shareholder rights li... See more »
August 6, 2018MarketersMedia

The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / July 9, 2018 / The Schall Law Firm, a national shareholder rights liti... See more »

Social Media

Akers Bio Headquarters

855 N Wolfe St, Suite 623

Baltimore, Maryland21205

1-813-864-2566

Driving Directions »

Trending Companies

Akers Bio Summary

ABOUT

Overview

Akers is a bioscience company that develops and supplies rapid screening and testing products to the healthcare sector. Akers Bio was founded in 1989. Akers Bio's headquarters is located in Baltimore, Maryland, USA 21205. It has raised 21.8M in 5 roun...

CEO

Akers Bio's Interim-CEO, Howard R. Yeaton, currently has an approval rating of 88%. Akers Bio's primary competitors are ACON, Immucor & OraSure.

Frequently Asked Questions about Akers Bio

  1. When was Akers Bio founded?

    Akers Bio was founded in 1989
  2. Who is Akers Bio's CEO?

    Akers Bio's CEO is Howard R. Yeaton
  3. How much revenue does Akers Bio generate?

    Akers Bio generates $ < 1M in revenue
  4. How much funding does Akers Bio have?

    Akers Bio has historically raised $21.8M in funding
  1. Where is Akers Bio's headquarters?

    Akers Bio's headquarters is in Baltimore Maryland, USA
  2. How many employees does Akers Bio have?

    Akers Bio has 4 employees
  3. What sector does Akers Bio operate in?

    Akers Bio is in Health Care Supplies
  4. Who are Akers Bio's competitors?

    Akers Bio's top competitors are ACON, Immucor, OraSure